Article Text

PDF
Hybrid SPECT/CT: the end of “unclear” medicine
  1. C N Patel,
  2. F U Chowdhury,
  3. A F Scarsbrook
  1. Department of Radiology, St James’s University Hospital, Leeds, UK
  1. Correspondence to Dr A F Scarsbrook, Department of Radiology, St James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK; andrew.scarsbrook{at}leedsth.nhs.uk

Abstract

The emergence of hybrid imaging, combining anatomical computed tomography (CT) and functional scintigraphic imaging has increased the armoury of techniques available to image disease. Single photon emission computed tomography/CT (SPECT/CT) is a dual modality technique which increases the sensitivity and specificity of existing radionuclide imaging and helps characterise equivocal lesions detected by other imaging methods. In addition to the many established clinical applications for SPECT/CT, there are new clinical uses emerging in a spectrum of benign and malignant diseases. In this article, we will discuss the established and emerging uses of hybrid SPECT/CT and illustrate the incremental value of the technique in a variety of clinical applications.

  • SPECT/CT
  • hybrid imaging
  • computed tomography
  • single photon emission computed tomography

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Provenance and Peer review Commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.